GLA and Lysosomal disease: Moreover, the correlation of the metabolic signature with plasma LysoGb3 levels and GalA enzymatic activity highlighted the metabolic reshaping of FD, and the diagnostic potential of omics-based approaches in lysosomal diseases [64].